Related Experiment Videos
Current concepts in clinical therapeutics: bacterial meningitis in infants and children
Insights
Bacterial meningitis is a serious infection in young children, primarily caused by specific bacteria. While antibiotics are crucial, current treatments haven't significantly reduced associated illness and death rates.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Bacterial meningitis is a leading cause of severe illness and death in children, particularly those under five.
- Key pathogens include Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae.
- Infection often begins with bacteremia or upper respiratory tract colonization, preceding invasion of the cerebrospinal fluid.
Purpose of the Study:
- To review the epidemiology, etiology, pathogenesis, clinical presentation, diagnosis, and treatment principles of bacterial meningitis in infants and children.
Main Methods:
- Review of existing literature on bacterial meningitis in pediatric populations.
- Analysis of diagnostic approaches, including clinical history and lumbar puncture findings.
- Evaluation of therapeutic strategies based on antimicrobial pharmacodynamics and supportive care.
Main Results:
- Clinical signs can be nonspecific, necessitating reliance on patient history and initial diagnostic tests.
- Effective treatment requires achieving adequate cerebrospinal fluid bactericidal activity, with drug penetration being critical.
- Empiric antibiotic therapy, often using penicillins, aminoglycosides, chloramphenicol, or newer cephalosporins, is initiated before definitive culture results.
Conclusions:
- Despite advances in antimicrobial agents like expanded-spectrum cephalosporins, significant reductions in morbidity and mortality have not been achieved.
- Aggressive supportive care is essential.
- Future research should explore novel nonantibiotic treatments for bacterial meningitis in children.
Abstract:
The epidemiology and incidence, etiology, pathogenesis and pathophysiology, clinical presentation, diagnosis, principles of therapy, and treatment of bacterial meningitis in infants and children are reviewed. Bacterial meningitis is a major cause of morbidity and mortality, and most cases occur in children less than five years old. Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae are the major pathogens involved. Bacteremia or colonization of the upper-respiratory-tract epithelium often precedes meningitis. Defense mechanisms are poor in the cerebrospinal fluid; once an organism penetrates the blood-brain barrier, infection may follow quickly. Clinical signs and symptoms are somewhat nonspecific, with lethargy, restlessness, and poor feeding prominent; diagnosis often relies on the patient history along with preliminary results of lumbar punctures. Therapy is based on pharmacologic and pharmacodynamic principles concerning the available antimicrobial agents, the blood-brain barrier, and supportive therapy. Effective antimicrobial therapy requires attainment of adequate bactericidal activity in the cerebrospinal fluid; penetration of agents into the brain depends on their physico-chemical characteristics. Antibiotic therapy must generally be started before culture results are available, making empiric therapy based on the child's age, history, and underlying conditions important. Established therapeutic agents include penicillins, aminoglycosides, and chloramphenicol, though newer expanded-spectrum cephalosporins such as cefuroxime, ceftriaxone, and cefotaxime are being used with increasing frequency. However, the use of these newer, more potent antimicrobial agents have not appreciably altered associated morbidity and mortality. Aggressive supportive care and evaluation of newer nonantibiotic treatments should be addressed in future studies of bacterial meningitis in infants and children.